• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS GLUCOSE HK GEN.3; GLUCOSE HEXOKINASE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS GLUCOSE HK GEN.3; GLUCOSE HEXOKINASE Back to Search Results
Catalog Number 08057800190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/29/2022
Event Type  malfunction  
Event Description
The initial reporter stated they received questionable results for one patient sample tested with gluc3 glucose hk gen.3 on two cobas pro c503 modules.The sample initially resulted in a glucose value of 3.68 mmol/l on the first c503 system (serial number (b)(4)) and this vale was reported outside of the laboratory to the clinician.The clinician asked for a new sample to be collected from the patient and tested as the result was not consistent with the patient's clinical status and the patient had a capillary glucose result of 1.2 mmol/l.The sample was repeated on a second c503 analyzer (serial number unknown) and the result was identical to the first value.A second sample collected from the patient resulted in a glucose value of 1.0 mmol/l when tested on the first c503 system.A new capillary sample collected from the patient resulted in a glucose value of 1.1 mmol/l.The complained sample was later repeated on the first c503 system on (b)(6) 2022, resulting in a glucose value of 3.99 mmol/l.The glucose reagent lot number and expiration date used for the first measurement were requested, but not provided.The second measurement of the sample performed on (b)(6) 2022 was tested using glucose reagent lot 614042.The reagent expiration date was requested, but not provided.
 
Manufacturer Narrative
Quality control data from february 2022 to april 2022 was provided and was within specifications.A general reagent issue can be excluded.The investigation could not identify a product problem.The cause of the event could not be determined.The issue is consistent with incorrect pre-analytic sample handling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GLUCOSE HK GEN.3
Type of Device
GLUCOSE HEXOKINASE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key14208533
MDR Text Key290082643
Report Number1823260-2022-01182
Device Sequence Number1
Product Code CFR
UDI-Device Identifier07613336121283
UDI-Public07613336121283
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K191899
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number08057800190
Device Lot NumberASKU, 614042
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-